Originally posted by AllSeq
View Post
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
-
Happy to help. The new chemistry is called Hi-Q. An early access program for it was announced at ASHG, with a full launch expected around July this year. In theory it's already available to PGM customers (via the early access program), but I haven't heard much about it since the original announcement. You can read more about it here: http://ir.lifetechnologies.com/relea...leaseID=798937
Comment
-
Originally posted by AllSeq View PostHappy to help. The new chemistry is called Hi-Q. An early access program for it was announced at ASHG, with a full launch expected around July this year. In theory it's already available to PGM customers (via the early access program), but I haven't heard much about it since the original announcement. You can read more about it here: http://ir.lifetechnologies.com/relea...leaseID=798937
Comment
-
Originally posted by ymc View PostAny updated answer to my question posted a year ago???
Is Proton 2 chip a vaporware?
Comment
-
lets see what comes new from IT on ASHG, I know Illumina will come with some more things but all of them have ben announced previously. Last thing i heard from a customer was that P2 will be around 20Gb of output so way below a killer for a Hiseq, NextSeq or a MiSeq.
Much more interesting is the bench top from CG/BGI and whatever Quiagen will release at some point for the clinical sector but also there i have no news (maybe All Seq has?? )
Comment
-
Originally posted by Buzz0r View PostMuch more interesting is the bench top from CG/BGI and whatever Quiagen will release at some point for the clinical sector but also there i have no news (maybe All Seq has?? )
As for the Qiagen/IBS GeneReader, we've not heard much about that lately. With the push that the MiSeq and now the PGM are making into the clinic, the longer the GeneReader takes to get to the market, the harder it will be for Qiagen to win marketshare. Hopefully we'll all learn more at ASHG or AGBT.
Comment
-
Originally posted by Buzz0r View Postlets see what comes new from IT on ASHG, I know Illumina will come with some more things but all of them have ben announced previously. Last thing i heard from a customer was that P2 will be around 20Gb of output so way below a killer for a Hiseq, NextSeq or a MiSeq.
Much more interesting is the bench top from CG/BGI and whatever Quiagen will release at some point for the clinical sector but also there i have no news (maybe All Seq has?? )
Qiagen has gone silent, but they went on an acquisition spree getting things lined up. It'll be interesting to see how they package it all together.
Comment
-
Originally posted by snetmcom View Post20GB seems unlikely given the throughput of the P1 is almost there. Read number might be more interesting.
Read number should be substantially higher - >300M useable reads per chip. If they hit that, the PII could be a really nice machine for 'counting' applications where shorter read length and lower quality can be better tolerated.
But that's still a niche and not a HiSeq-killer.
Comment
-
Hi all!
My institute will purchase a benchtop sequencer for bacterial genome sequencing. It will be used both for routine genome seq and (importantly) for infetious disease outbreak analyses. Hence, although only one of many important parameters, time from DNA isolation to results is important.
I am positively inclined towards the MiSeq, as I have only good experience with Illumina data (HiSeq and MiSeq). However, at a presentation at the institute, they weren´t really that impressive. Ion Torrent, on the other hand sent an expert on bacterial genome sequencing, who, it seems managed to sway a lot of people.
I find it difficult to make a sound comparison. The published literature largely favors MiSeq for quality of sequences and throughput. However, Ion Torrent claims that the Ion 318 v2 Chip yields improved quality. And throughput isn´t necessarily that important. They also claim that library prepping is fast (<2 hrs) and automated.
Also, what convinced people at my institute was data handling: the Ion Torrent seems to come with built-in software that can output variant calls and that can be tailor maid for various outputs (e.g. resistance gene mutations etc). This sounds nice, but I have a feeling that this way of doing things is not very flexible…
Some specific questions:
-Has anyone experience with long read MiSeq (2x250 or so) AND Ion torrent (418 bp reads)? Any thoughts on whats best?
-Is mate-pair sequencing on Ion Torrent something that must be done in a separate run following «normal» single end sequencing?
-Even though Ion Torrent is a lot more bulky and has more steps, It seems like it is a lot faster than MiSeq long reads. Is that correct?
-Is it problematic doing comparative genomic analyses with data from Illumina and Ion torrent together?
-M. tuberculosis (65% GC content) is among the bacteria that will be sequenced routinely. Ion Torrent seems to suck at high GC but I have only found one paper on this. How much is this of a problem? Ion Torrent showcased the use of Ion Torrent for quick resistance determination in M. tuberculosis, but this scheme relied on amplicon sequencing, which in my view is a bit like walking backwards into the future……
Please excuse this chaotic post, but there are so many questions...
All feedback appreciated,
Vegard
Comment
-
Originally posted by vehuardo View PostHi all!
My institute will purchase a benchtop sequencer for bacterial genome sequencing. It will be used both for routine genome seq and (importantly) for infetious disease outbreak analyses. Hence, although only one of many important parameters, time from DNA isolation to results is important.
I am positively inclined towards the MiSeq, as I have only good experience with Illumina data (HiSeq and MiSeq). However, at a presentation at the institute, they weren´t really that impressive. Ion Torrent, on the other hand sent an expert on bacterial genome sequencing, who, it seems managed to sway a lot of people.
I find it difficult to make a sound comparison. The published literature largely favors MiSeq for quality of sequences and throughput. However, Ion Torrent claims that the Ion 318 v2 Chip yields improved quality. And throughput isn´t necessarily that important. They also claim that library prepping is fast (<2 hrs) and automated.
Also, what convinced people at my institute was data handling: the Ion Torrent seems to come with built-in software that can output variant calls and that can be tailor maid for various outputs (e.g. resistance gene mutations etc). This sounds nice, but I have a feeling that this way of doing things is not very flexible…
Some specific questions:
-Has anyone experience with long read MiSeq (2x250 or so) AND Ion torrent (418 bp reads)? Any thoughts on whats best?
-Is mate-pair sequencing on Ion Torrent something that must be done in a separate run following «normal» single end sequencing?
-Even though Ion Torrent is a lot more bulky and has more steps, It seems like it is a lot faster than MiSeq long reads. Is that correct?
-Is it problematic doing comparative genomic analyses with data from Illumina and Ion torrent together?
-M. tuberculosis (65% GC content) is among the bacteria that will be sequenced routinely. Ion Torrent seems to suck at high GC but I have only found one paper on this. How much is this of a problem? Ion Torrent showcased the use of Ion Torrent for quick resistance determination in M. tuberculosis, but this scheme relied on amplicon sequencing, which in my view is a bit like walking backwards into the future……
Please excuse this chaotic post, but there are so many questions...
All feedback appreciated,
Vegard
Comment
-
We bought the MiSeq when the PGM came out and was still comparable with the MiSeq. I don't know about Ion, but it seems the MiSeq simply works... consistently and as advertised. I've read in other reviews the Ion prep is very tricky but I'm not sure if that still applies with their new kits and machines. I would also take into consideration that there is a chance Ion won't survive given that they have fallen behind in all their promises. There are few niche applications where the PGM is better than the MiSeq, I'm not sure if these are enough to sustain their market, make sure that you don't buy a machine that will be discontinued in a few years.
Comment
-
Originally posted by aleferna View PostWe bought the MiSeq when the PGM came out and was still comparable with the MiSeq. I don't know about Ion, but it seems the MiSeq simply works... consistently and as advertised. I've read in other reviews the Ion prep is very tricky but I'm not sure if that still applies with their new kits and machines. I would also take into consideration that there is a chance Ion won't survive given that they have fallen behind in all their promises. There are few niche applications where the PGM is better than the MiSeq, I'm not sure if these are enough to sustain their market, make sure that you don't buy a machine that will be discontinued in a few years.
Comment
-
Originally posted by vehuardo View PostHi all!
My institute will purchase a benchtop sequencer for bacterial genome sequencing. It will be used both for routine genome seq and (importantly) for infetious disease outbreak analyses. Hence, although only one of many important parameters, time from DNA isolation to results is important.
I am positively inclined towards the MiSeq, as I have only good experience with Illumina data (HiSeq and MiSeq). However, at a presentation at the institute, they weren´t really that impressive. Ion Torrent, on the other hand sent an expert on bacterial genome sequencing, who, it seems managed to sway a lot of people.
I find it difficult to make a sound comparison. The published literature largely favors MiSeq for quality of sequences and throughput. However, Ion Torrent claims that the Ion 318 v2 Chip yields improved quality. And throughput isn´t necessarily that important. They also claim that library prepping is fast (<2 hrs) and automated.
Also, what convinced people at my institute was data handling: the Ion Torrent seems to come with built-in software that can output variant calls and that can be tailor maid for various outputs (e.g. resistance gene mutations etc). This sounds nice, but I have a feeling that this way of doing things is not very flexible…
Some specific questions:
-Has anyone experience with long read MiSeq (2x250 or so) AND Ion torrent (418 bp reads)? Any thoughts on whats best?
-Is mate-pair sequencing on Ion Torrent something that must be done in a separate run following «normal» single end sequencing?
-Even though Ion Torrent is a lot more bulky and has more steps, It seems like it is a lot faster than MiSeq long reads. Is that correct?
-Is it problematic doing comparative genomic analyses with data from Illumina and Ion torrent together?
-M. tuberculosis (65% GC content) is among the bacteria that will be sequenced routinely. Ion Torrent seems to suck at high GC but I have only found one paper on this. How much is this of a problem? Ion Torrent showcased the use of Ion Torrent for quick resistance determination in M. tuberculosis, but this scheme relied on amplicon sequencing, which in my view is a bit like walking backwards into the future……
Please excuse this chaotic post, but there are so many questions...
All feedback appreciated,
Vegard
I've been using both platforms for a while now and I'd say they are good at different things. Compared to the MiSeq, the PGM has lower max throughput, period. However the throughput of the PGM can be scaled depending on the chip you use. Currently there are three different chip sizes (314, 316 and 318). The 314 chip is the cheapest but also gives you the least amount of reads. We found this very useful as we would receive a small number of very high priority clinical samples that would not, by themselves fill a MiSeq run, thus wasting reagent.
When it comes to sample-prep, there's the IonChef that automates a lot of the pre-sequencing workflow, we've had it for a while now and it works really well. The only downside is that it requires 2 chips per run, so either you'll have to run 2 chips concurrently (not necessarily with the same libraries mind you) or have 2 PGM's. The library prep using the Chef is also straighforward, minimizing user error. There is also a new chemistry called Hi-Q that decreases error rates and increases overall sequence quality.
The IonTorrent server that takes care of the data can indeed be made to do variant calls and similar, generally we preferred to download the data instead and use CLC for mapping and variant-calling so i don't have that much experience with the inbuilt one. The server does support plugins though, so you can easily write your own pipeline in perl/python and make it run on your data directly on the server.
-I'm using both, mainly you see a difference in error profiles, the PGM is more inclined at having troubles in homopolymers while the MiSeq is more evenly spaced out.
-Mate pair on the PGM is fairly new, but it does not require an extra step, the sample prep is more complicated though.
-Running time varies a bit with what kind of chip you use, but usually its something like 6-10 hours after loading it on the instrument. The chef requires an additional 10-12 hours if i remember correctly, so we usually loaded the chips into the chef before we went home and then ran the PGM the morning after.
-When combining datasets, the different error profiles could mess with your analysis, there are a few read-error correction tools available (Hammer from the SPAdes pipeline for e.g.) that could help.
-We routinely used the PGM for bacterial sequencing (Listeria and other food-borne diseases) but also for parasites and similar. The PGM performed admirably at both tasks, from 30% GC to 65% as far as we could tell.
Bottom line:
If you have a large volume of samples that arrive continuously (so you can maximize the throughput of the MiSeq) and turnaround time is not a critical aspect, the MiSeq is probably the better choice. If you have a varying amount of samples that need to be turned around quickly, you are better of with a PGM.
//tracer
Comment
Latest Articles
Collapse
-
by seqadmin
Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...-
Channel: Articles
12-16-2024, 07:57 AM -
-
by seqadmin
Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.
Long-Read Sequencing
Long-read sequencing has seen remarkable advancements,...-
Channel: Articles
12-02-2024, 01:49 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 12-17-2024, 10:28 AM
|
0 responses
26 views
0 likes
|
Last Post
by seqadmin
12-17-2024, 10:28 AM
|
||
Started by seqadmin, 12-13-2024, 08:24 AM
|
0 responses
42 views
0 likes
|
Last Post
by seqadmin
12-13-2024, 08:24 AM
|
||
Started by seqadmin, 12-12-2024, 07:41 AM
|
0 responses
28 views
0 likes
|
Last Post
by seqadmin
12-12-2024, 07:41 AM
|
||
Started by seqadmin, 12-11-2024, 07:45 AM
|
0 responses
42 views
0 likes
|
Last Post
by seqadmin
12-11-2024, 07:45 AM
|
Comment